Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis

Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis | RMD Open: "Giant cell arteritis (GCA) is a chronic systemic vasculitis affecting large-sized and medium-sized vessels. Glucocorticoids are currently the mainstay of treatment for GCA and associated large vessel vasculitis (LVV) but are associated with frequent adverse events....Tocilizumab (TCZ), a humanised antihuman IL-6 receptor antibody, has been used successfully in several reports as a treatment for GCA and LVV."